a composition comprises a compound of formula 1 : a pharmaceutically acceptable salt , hydrate , solvate , crystal form , diastereomer , prodrug , or mixture thereof , wherein w is a nitrogen - substituted 5 - or 6 - membered monocyclic ring . the compounds are of utility as modulators of kinase activity .